Advertisement

Critical considerations on the predictive value of end-of-treatment FDG-PET in lymphoma

  • Hugo J. A. AdamsEmail author
  • Thomas C. Kwee
Letter to the Editor

Notes

Author contributions

Hugo J.A. Adams: study design, article writing, final approval of the manuscript.

Thomas C. Kwee: study design, article writing, final approval of the manuscript.

Compliance with ethical standards

Funding

This work was financially supported by an Alpe d’HuZes/Dutch Cancer Society Bas Mulder Award for T.C.K. (grant number 5409). Data collection, data analysis, and interpretation of data, writing of the paper, and decision to submit were left to the authors’ discretion and were not influenced by Alpe d’HuZes/Dutch Cancer Society.

Conflict of interest

None (all authors).

References

  1. 1.
    Fallanca F, Alongi P, Incerti E, Gianolli L, Picchio M, Kayani I, et al. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville criteria (DC) and the international harmonization project criteria (IHPC). Eur J Nucl Med Mol Imaging. 2016. doi: 10.1007/s00259-016-3390-9.CrossRefGoogle Scholar
  2. 2.
    An YS, Yoon JK, Lee SJ, Jeong SH, Lee HW. Clinical significance of post-treatment F-fluorodeoxyglucose uptake in cervical lymph nodes in patients with diffuse large B-cell lymphoma. Eur Radiol. 2016. doi: 10.1007/s00330-016-4365-8.CrossRefGoogle Scholar
  3. 3.
    Avivi I, Zilberlicht A, Dann EJ, Leiba R, Faibish T, Rowe JM, et al. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era. Am J Hematol. 2013;88:400–5. doi: 10.1002/ajh.23423.CrossRefGoogle Scholar
  4. 4.
    Zinzani PL, Tani M, Trisolini R, Fanti S, Stefoni V, Alifano M, et al. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. Haematologica. 2007;92:771–7.CrossRefGoogle Scholar
  5. 5.
    Nakayama H, Aisa Y, Ito C, Shimazaki K, Katsumata Y, Hayashi H, et al. Importance of histologic verification of positive positron emission tomography/computed tomography findings in the follow-up of patients with malignant lymphoma. Clin Lymphoma Myeloma Leuk. 2015;15:753–60. doi: 10.1016/j.clml.2015.07.636.CrossRefGoogle Scholar
  6. 6.
    Adams HJ, Nievelstein RA, Kwee TC. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol. 2015;170:185–91. doi: 10.1111/bjh.13420.CrossRefGoogle Scholar
  7. 7.
    Adams HJ, Kwee TC. Both interim and end-of-treatment 18F-fluoro-2-deoxy-d-glucose positron emission tomography scans have low value in diffuse large B-cell lymphoma. J Clin Oncol. 2016;34:765–6. doi: 10.1200/JCO.2015.63.7728.CrossRefGoogle Scholar
  8. 8.
    Adams HJ, Kwee TC. Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Br J Haematol. 2016. doi: 10.1111/bjh.14052.CrossRefGoogle Scholar
  9. 9.
    Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, et al. An enhanced international prognostic index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–42. doi: 10.1182/blood-2013-09-524108.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International prognostic factors project on advanced Hodgkin’s disease. N Engl J Med. 1998;339:1506–14. doi: 10.1056/NEJM199811193392104.CrossRefGoogle Scholar
  11. 11.
    Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104:1258–65. doi: 10.1182/blood-2003-12-4434.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  1. 1.Department of Radiology and Nuclear MedicineUniversity Medical Center UtrechtUtrechtThe Netherlands
  2. 2.Department of Radiology, Nuclear Medicine and Molecular ImagingUniversity Medical Center GroningenGroningenThe Netherlands

Personalised recommendations